Monopar Therapeutics Inc
F:1IY
Monopar Therapeutics Inc
F:1IY
Price:
1.85
EUR
Market Closed
Market Cap:
€32.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Monopar Therapeutics Inc
F:1IY
|
US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
T
|
TAL Education Group
SWB:IZZ
|
CN |
|
Getlink SE
PAR:GET
|
FR |
|
S
|
Stellantis NV
XBER:8TI
|
NL |
|
S
|
Stellantis NV
XMUN:8TI
|
NL |
Wall St Price Targets
1IY Price Targets Summary
Monopar Therapeutics Inc
Monopar Therapeutics Inc
Wall Street analysts forecast 1IY stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1IY is 1.93 EUR with a low forecast of 1.64 EUR and a high forecast of 2.22 EUR.
Lowest Forecast
Price Target
1.64
EUR
11% Downside
Average Forecast
Price Target
1.93
EUR
5% Upside
Highest Forecast
Price Target
2.22
EUR
20% Upside
Monopar Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1IY's stock price target?
Price Target
1.93
EUR
1.93
EUR
According to Wall Street analysts, the average 1-year price target for 1IY is 1.93 EUR with a low forecast of 1.64 EUR and a high forecast of 2.22 EUR.
